This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignees: Scripps Research Institute, International Aids Vaccine Initiative. Active years: 2021-2026.
Company Filing History:
4 out of 1,204 
3 out of 71 
Years Active: 2021-2026
Title: Jon M Steichen: Innovator in HIV Research
Introduction
Jon M Steichen is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of HIV research, holding 4 patents that focus on innovative approaches to treatment and prevention of HIV/AIDS. His work has been instrumental in advancing our understanding of HIV and developing potential therapeutic strategies.
Latest Patents
Steichen's latest patents include "Recombinant HIV Env polypeptides and their use," which relates to the development of recombinant HIV Env polypeptides aimed at treating and preventing HIV/AIDS. Another notable patent is "Immunogenic trimers," which involves PGT121-germline-targeting designs, trimer stabilization designs, and the development of trimer nanoparticles for immunization regimens.
Career Highlights
Throughout his career, Jon M Steichen has worked with esteemed organizations such as the International Aids Vaccine Initiative and The Scripps Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include William R Schief and Dan Kulp. Their collaborative efforts have further enhanced the impact of Steichen's work in HIV research.
Conclusion
Jon M Steichen's innovative contributions to HIV research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future developments in the field.